Skip to main content

Table 2 Effect of ulinastatin on postoperative clinical course

From: Preventive effect of ulinastatin on postoperative complications, immunosuppression, and recurrence in esophagectomy patients

 

Control (n = 40)

Ulinastatin (n = 40)

P

Cardiovascular complications

1

1

1

Pulmonary complications

8

1

0.034

Anastomosis leakage

1

1

1

Anastomosis stenosis

1

0

1

Wound infection

1

1

1

Total

12

4

0.034

Death

1

0

1

Duration of ICU stay (hours)

45 ± 24

33 ± 16

0.01

Length of hospital stay (days)

11 ± 4

10 ± 2

0.170